CompaniesPROGEN
PROGEN logo

PROGEN

active
Heidelberg, Germany
Founded 1983
Website
About

Antibodies, in vitro diagnostics, ELISA, AAV

Areas of Focus

Categories

DiagnosticsNon-PharmaceuticalAntibody
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

105

By Phase

PHASE2: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
NCT05528952
Hover over trial bars to see details

Recent Trials

NCT05528952Collaborator
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
PHASE2Recruiting
105 participants
Started: Sep 27, 2022 · Completed: Feb 27, 2030
Locations (1)
Headquarters
Heidelberg, Germany
Map

Loading map...